(1S)-6-carbazol-9-yl-5-(12-phenyl-[1]benzothiolo[2,3-a]carbazol-8-yl)cyclohexa-2,4-diene-1-carbonitrile
C43H27N3S — CID 126596714
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S)-6-carbazol-9-yl-5-(12-phenyl-[1]benzothiolo[2,3-a]carbazol-8-yl)cyclohexa-2,4-diene-1-carbonitrile
(1S)-6-carbazol-9-yl-5-(12-phenyl-[1]benzothiolo[2,3-a]carbazol-8-yl)cyclohexa-2,4-diene-1-carbonitrile (PubChem CID 126596714) has the molecular formula C43H27N3S and a molecular weight of 617.78 g/mol. Its IUPAC name is (1S)-6-carbazol-9-yl-5-(12-phenyl-[1]benzothiolo[2,3-a]carbazol-8-yl)cyclohexa-2,4-diene-1-carbonitrile.
Molecular Properties
| Compound Name | (1S)-6-carbazol-9-yl-5-(12-phenyl-[1]benzothiolo[2,3-a]carbazol-8-yl)cyclohexa-2,4-diene-1-carbonitrile |
|---|---|
| PubChem CID | 126596714 |
| Molecular Formula | C43H27N3S |
| Molecular Weight | 617.78 g/mol |
| Exact Mass | 617.19 |
| IUPAC Name | (1S)-6-carbazol-9-yl-5-(12-phenyl-[1]benzothiolo[2,3-a]carbazol-8-yl)cyclohexa-2,4-diene-1-carbonitrile |
| SMILES | N#C[C@H]1C=CC=C(c2ccc3sc4c(ccc5c6ccccc6n(-c6ccccc6)c54)c3c2)C1n1c2ccccc2c2ccccc21 |
| InChI | InChI=1S/C43H27N3S/c44-26-28-11-10-17-30(41(28)46-38-19-8-4-14-31(38)32-15-5-9-20-39(32)46)27-21-24-40-36(25-27)35-23-22-34-33-16-6-7-18-37(33)45(42(34)43(35)47-40)29-12-2-1-3-13-29/h1-25,28,41H/t28-,41?/m1/s1 |
| InChIKey | AAOSSCPCIGSPCP-MEUHZGSUSA-N |
| XLogP | 11.59 |
| TPSA | 33.65 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 617.78 |
| LogP ≤ 5 | 11.59 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126596714 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.